Skip to content

Assessment of Eye safety of Baby Products in Adults

Assessment of Ophthalmologic Safety and Tolerability of Baby Products in Adults - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107275
Enrollment
36
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Baby Wash: Single instillation of 15 microliters of 10 percent diluted randomized test product in the randomized eye and distilled water in the other eye Intervention2: Baby Shampoo: Si

Sponsors

Mother Sparsh Baby Care Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with no medical conditions of the eye as determined by the subjects medical history and confirmed by the ophthalmologist. 2. Subjects not under any doctors care for or peri orbital diseases. 3. Subjects willing to refrain from using any topical facial products, any eyedrops, false eyelashes, make-up, over the counter products, or cosmetics on their eyes, eyelids, eyelashes, or the periorbital areas of the face during the study. 4. Subjects in good health and willing to provide written informed consent and attend regular follow-up visits. 5. Subjects willing to comply with the study protocol and refrain from participating in any other clinical study during the current study.

Exclusion criteria

Exclusion criteria: 1. Subject with conjunctival, corneal, or periocular conditions, orthose using contact lenses. 2. Subject with known history or present allergic condition that may require medical attention. 3. Subject with chronic illness which may influence the cutaneous assessment. 4.Subjects on any systemic medication or with birth defect and anomalies. 5. Subjects with a past or present history of significant ophthalmological disease or conditions, or those judged by the investigator to be inappropriate for this trial.

Design outcomes

Primary

MeasureTime frame
Mean change in the ocular irritation potential as per Ophthalmologist assessment.Timepoint: 0 hour, 30 seconds, 15 minutes, 60 minutes, 24 hours

Secondary

MeasureTime frame
Mean change in the ocular reaction as per Ophthalmologist assessment on using the test product.Timepoint: 0 hour, 30 seconds, 15 minutes, 60 minutes, 24 hours;Mean change in the ocular irritation severity scores as per subjects assessment on using the test product.Timepoint: 0 hour, 30 seconds, 15 minutes, 60 minutes, 24 hours

Countries

India

Contacts

Public ContactJestin V Thomas

Leads Clinical Research and Bio Services Pvt. Ltd.

jestin.leadsclinbio@gmail.com9845125293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026